Terminalcare Support Institute, Inc. (7362) AI Stock Analysis

• Market Cap: ¥1.30B
• Dividend Yield: N/A
• Average Volume (3M): 2.38K
• Price to Earnings (P/E): 15.3
• Beta (1Y): 0.36
• Revenue Growth: 9.76%
• EPS Growth: -10.10%
• Country: JP
• Employees: 451
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 23.55
• Shares Outstanding: 1,533,100
• 10 Day Avg. Volume: 1,960
• 30 Day Avg. Volume: 2,376
• PEG Ratio: -1.24
• Price to Book (P/B): 1.06
• Price to Sales (P/S): 0.30
• P/FCF Ratio: -1.75
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 64 Neutral
• Price Target: ¥883.00 ▲(7.55% Upside)

The overall score reflects solid financial performance with growth in revenues and stable gross margins, but challenges in profitability and rising debt levels are concerns. Technical analysis indicates bearish momentum, while valuation is reasonable. The absence of earnings call data and corporate events limits further insights.

Terminalcare Support Institute, Inc. Business Overview & Revenue Model

Company Description

Terminalcare Support Institute, Inc. (7362) is a specialized organization focused on providing comprehensive support and educational services in the healthcare sector, particularly targeting end-of-life care and terminal illness management. The institute offers a range of products and services, including training programs for healthcare professionals, resources for families dealing with terminal illnesses, and consultation services aimed at improving care practices in hospice and palliative settings. By leveraging a multidisciplinary approach, the organization aims to enhance the quality of life for patients and provide support to their families during challenging times.

How the Company Makes Money

Terminalcare Support Institute, Inc. generates revenue through multiple streams, including tuition fees from training and certification programs offered to healthcare professionals, consultation fees for personalized care strategy development, and sales of educational materials and resources related to terminal care. Additionally, the company may partner with healthcare institutions and organizations to provide tailored training solutions, earning revenue through service contracts. Grants and funding from healthcare foundations and government programs aimed at improving palliative care practices also contribute to the company's financial sustainability.

Terminalcare Support Institute, Inc. Financial Statement Overview

Summary

The company shows solid revenue growth and stable gross margins. However, declining net profit margins and return on equity indicate challenges in profitability. The balance sheet is strong but rising debt levels are a concern. Cash flow management needs improvement due to high capital expenditures affecting free cash flow.

Income Statement

The company has demonstrated consistent revenue growth over the years, with a notable increase from 2023 to 2024. Gross profit margins have remained stable, indicating effective cost management. However, net profit margins have slightly decreased, which may suggest rising expenses or other cost pressures. EBIT and EBITDA margins show operational efficiency, but there is room for improvement in profitability.

Balance Sheet

The balance sheet reflects a moderate debt-to-equity ratio, indicating a balanced approach to leverage. The equity ratio is healthy, suggesting a strong asset base relative to liabilities. However, the increase in total debt over the years could pose a risk if not managed carefully. Return on equity has decreased, highlighting a need for improved profitability to enhance shareholder returns.

Cash Flow

Operating cash flow has been positive, supporting the company's operational needs. However, free cash flow has been negative in recent years due to high capital expenditures, which could limit financial flexibility. The operating cash flow to net income ratio is strong, indicating efficient cash generation from operations. The company needs to manage its capital expenditures to improve free cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	4.78B	4.71B	4.25B	4.10B	3.40B	2.93B
Gross Profit	652.76M	664.67M	646.76M	685.84M	599.50M	464.84M
EBITDA	277.80M	321.42M	300.83M	334.75M	284.93M	237.34M
Net Income	83.49M	113.77M	126.67M	157.54M	138.03M	102.29M
Balance Sheet
Total Assets	5.32B	4.80B	4.09B	3.03B	2.88B	2.06B
Cash, Cash Equivalents and Short-Term Investments	887.13M	1.13B	1.38B	1.09B	874.72M	411.85M
Total Debt	3.26B	2.81B	2.26B	1.34B	1.43B	1.44B
Total Liabilities	4.00B	3.49B	2.90B	1.95B	1.95B	1.82B
Stockholders Equity	1.32B	1.31B	1.19B	1.08B	927.37M	237.34M
Cash Flow
Free Cash Flow	0.00	-797.40M	-597.43M	303.05M	-57.27M	51.51M
Operating Cash Flow	0.00	304.51M	238.18M	812.73M	462.19M	124.89M
Investing Cash Flow	0.00	-1.10B	-836.33M	-510.68M	-523.54M	-74.58M
Financing Cash Flow	0.00	545.64M	892.46M	-90.11M	523.02M	-56.64M

Terminalcare Support Institute, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 821.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7362, the sentiment is Positive. The current price of 821 is below the 20-day moving average (MA) of 824.55, below the 50-day MA of 840.30, and below the 200-day MA of 829.75, indicating a bullish trend. The MACD of -7.79 indicates Negative momentum. The RSI at 56.37 is Neutral, neither overbought nor oversold. The STOCH value of 83.04 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7362.

Terminalcare Support Institute, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
9220	81 Outperform	¥3.04B	7.50	―	2.62%	5.37%	-9.33%
2425	75 Outperform	¥3.03B	11.54	―	2.53%	-3.06%	-38.56%
7133	74 Outperform	¥9.13B	12.98	―	1.60%	18.58%	-6.30%
7061	70 Neutral	¥11.42B	21.15	―	1.08%	18.03%	-11.68%
7129	68 Neutral	¥3.14B	9.35	―	2.67%	4.69%	103.59%
7362	64 Neutral	¥1.30B	15.25	―	―	9.76%	-10.10%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%